 Aimmune Therapeutics Inc NASDAQ:AIMT major shareholder Des Produits Nestle S. Societe acquired 1,525,634 shares of Aimmune Therapeutics stock in a transaction that occurred on Friday, February 7th. The stock was acquired at an average price of 131.09 per share, with a total value of 199,995,361.06. The purchase was disclosed in a legal filing with the ... 